Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RAAS and Glucose Metabolism in Metabolic Syndrome
NCT02034435Phase 4Completed
- Sponsor
- Vanderbilt University Medical Center
- Start
- Oct 2013
- Primary completion
- Dec 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of eplerenone in metabolic syndrome, sponsored by Vanderbilt University Medical Center. Started Oct 2013; status: completed.
02
Drugs
eplerenone
03
Conditions
metabolic syndrome
Beyond the preview
Go deeper on NCT02034435.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02034435.